6Chambless L, Keil U, Dobson A, et al.Population versus clinical, view of case fatality from acute coronary heartdisease. Results from the WHO MONICA project 1985-1990 [J]. Circulation, 1997,96 : 3849-3859. 被引量：1
7Gu DF,Wu XG,Xin X,et al. Prevalence of cardiovascular disease in China: The International Collaborative Study of Cardiovascular disease in ASIA (inter ASIA) [R]. 42nd Annual Conference on Cardiovascular Disease Epidemiology and Prevention. American Heart Association Fighting Heart Disease and Stroke April 2002 Hawaii. 被引量：1
8Wielgosz AT, Lynne MC. Cardiovascular disease in the Americans: Current dataand future needs [J] .CVD Prevention,1998,1: 71-81. 被引量：1
6Francesco MR, Tischa C, Albert F, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study [J].Circulation, 2006, 113 (5) 657-663. 被引量：1
7Wang X, Keith JC, Struthers AD, et al. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk [J]. Cardiovasc Ther,2008, 26(3) :214-223. 被引量：1
8Gosse P, Roche F, Dauphinot V, et al. Components of arterial stiffness in a population of 65-year-old subjects: PROOF study[J].J Hypertens, 2008,26(6): 1 138- 1 146. 被引量：1
9Rizzo M, Corrado E, Coppola G, et al. Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis., the role of Creactive protein[J]. J Investig Med, 2008,56 (1) : 32- 40. 被引量：1
10Coutinho A, Turner ST, Peyser PA, et al. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis[J]. Am J Hypertens,2007, 20(1):83-89. 被引量：1
